In March, the tobacco giant took a 20% stake in Canadian medical cannabis maker Organigram and signed a deal to research a new range of adult cannabis products, initially focused on CBD.
from Hacker News https://ift.tt/2UVhwfm
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.